Ticker Details
Kymera Therapeutics, Inc.
IPO Date:	August 21, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.99B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.23 | 3.13%
Avg Daily Range (30 D):	$1.77 | 2.33%
Avg Daily Range (90 D):	$1.71 | 2.40%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.61M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	2,519
Avg Institutional Trade:	$2.65M
Avg Institutional Trade (30 D):	$4.31M
Avg Institutional Trade (90 D):	$4.47M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.67M
Avg Closing Trade (30 D):	$7.58M
Avg Closing Trade (90 D):	$8.56M
Avg Closing Volume:	94.43K

News

Jan 13, 2026 @ 12:00 PM Kymera Therapeutics Outlines Key 2026 Objectives a... Source: Kymera Therapeutics

Jan 2, 2026 @ 5:30 PM Insider Buying: Smart Money Just Spent +$100M on T... Source: Leo Miller

Dec 11, 2025 @ 9:01 PM Kymera Therapeutics Announces Closing of Upsized $... Source: Globe Newswire

Dec 10, 2025 @ 4:30 AM Kymera Therapeutics Announces Pricing of Upsized $... Source: Justine Koenigsberg

Nov 25, 2025 @ 12:00 PM Kymera Therapeutics Announces First Patient Dosed ... Source: Kymera Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.6	$-.94	$-.95
Diluted EPS	$-3.6	$-.94	$-.95
Revenue	$43.73M	$2.76M	$11.48M
Gross Profit	$M	$M	$M
Net Income / Loss	$-295.12M	$-82.18M	$-76.61M
Operating Income / Loss	$-332.26M	$-92.52M	$-84.56M
Cost of Revenue	$43.74M	$2.76M	$11.48M
Net Cash Flow	$2.24M	$-222.9M	$245.86M
PE Ratio